They can secrete immunosuppressive cytokines (interleukin 6 (IL-6), IL-17, and tumor growth factor beta (TGF-β)) into the tumor microenvironment, which has been associated with a poor clinical outcome [25,26]. The gene discussed is IL6; the disease is neoplasm.